SIRNA IN THE TREATMENT OF ECTRODACTYLY-ECTODERMAL DYSPLASIA-CLEFTING SYNDROME (EEC) - Patent 4225918

(19)

(11)

EP 4 225 918 A1

(12)

(43)	Date of publication:
	16.08.2023 Bulletin 2023/33

(21)	Application number: 21799330.2

(22)	Date of filing: 06.10.2021

(51)

International Patent Classification (IPC):

C12N 15/113^(2010.01)
A61K 31/713^(2006.01)

A61K 31/7088^(2006.01)
C12N 15/11^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C12N 15/113; C12N 2310/14; A61K 31/713; C12N 2320/34; C12N 2310/3231

(86)	International application number:
	PCT/IB2021/059160

(87)	International publication number:
	WO 2022/074579 (14.04.2022 Gazette 2022/15)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

07.10.2020 IT 202000023647

(71)	Applicant: Universita' Degli Studi Di Padova
	35122 Padova (IT)

(72)	Inventor:
	DI IORIO, Mario Vincenzo 30033 Noale (IT)

(74)	Representative: Zaccaro, Elisabetta et al
	Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30 20149 Milano 20149 Milano (IT)

(54)	SIRNA IN THE TREATMENT OF ECTRODACTYLY-ECTODERMAL DYSPLASIA-CLEFTING SYNDROME (EEC)